Antibody Engineering & Therapeutics
Antibody engineering is employed within the treatment of various diseases and lots of diagnostic tests. Every protein binds terribly specifically to just one form of cell or molecule and antibody technology permits researchers to focus on specific cells (Maynard).The applications of antibody engineering are prospering because of this specific binding of antibodies and antigens. Production ways of antibodies still progress, creating it potential to get antibodies specific to virtually any substance. Rising applications of antibody engineering embody cancer medical aid and radioimmunodetection of tumors. Antibodies present several exciting potentialities to the longer term of drugs.
- Engineering bi-specific antibodies
- Hybridoma and Phage Display Technology of antibodies
- Bi specific antibodies & combination therapy
- Antibodies for cancer therapy
- Antibody Repertoire Libraries
- Synthetic antibody libraries
- Medical Imaging
- Other uses of Antibodies
Related Conference of Antibody Engineering & Therapeutics
Antibody Engineering & Therapeutics Conference Speakers
Recommended Sessions
- Clinical Pathology
- Animal and Plant Biochemistry
- Antibody Engineering & Therapeutics
- Biochemistry in Cancer research
- Biomathematics and Biostatistics
- Biophysical techniques
- Biophysics
- Cellular and Molecular Biology
- Clinical & Forensic Biochemistry
- Computational Chemistry and Chemical Biology
- Environmental Biochemistry
- Enzymology and Biochemistry
- Epidemiology
- Food and Nutritional Biochemistry
- Gene Expression and Genetic Engineering
- Improving Rare Disease Diagnosis with Metabolomics
- Industrial & Structural Biochemistry
- Metabolic Biochemistry
- Metabolomic Technology and Bioinformatics
- Metabolomics in Ophthalmology
- Obesity and Metabolic Disorder
- Pharmaceutical Biochemistry
- Protein Engineering
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- Biochemistry - Glycobiology 2025 (Germany)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Evolution of Glycan Diversity - Glycobiology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene regulation and Cell Signalling - Structural Biology 2025 (Germany)
- Genomics and Metabolomics - Glycobiology 2025 (Germany)
- Glycans in Diseases and Therapeutics - Glycobiology 2025 (Germany)
- Glycans in Drug Design - Glycobiology 2025 (Germany)
- Glycan’s - Glycobiology 2025 (Germany)
- Glycobiology - Glycobiology 2025 (Germany)
- Glycochemistry - Glycobiology 2025 (Germany)
- Glycoimmunology - Glycobiology 2025 (Germany)
- Glycoinformatics - Glycobiology 2025 (Germany)
- Glycolipids and Glycopeptides - Glycobiology 2025 (Germany)
- Glyconeurobiology - Glycobiology 2025 (Germany)
- Glycopathology - Glycobiology 2025 (Germany)
- Glycosience - Glycobiology 2025 (Germany)
- Hybrid approaches in Structure prediction - Structural Biology 2025 (Germany)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular biology techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteoglycan and Sialic acid - Glycobiology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Recent Advances in Glycobiology - Glycobiology 2025 (Germany)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)
- Synthesis and Biological Role of Glycans - Glycobiology 2025 (Germany)